Product Information
IVABRADINE HCL 7.5 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.7371 per EA under NDC 70710147206. Its NADAC has been published 88 times since Oct 23, 2024.
Strength
7.5 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710147206
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IVABRADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213442On Market Since
7/2/2024
Pharmacological Classes
Price Statistics
The NADAC for IVABRADINE HCL 7.5 MG TABLET has been published 88 times since Oct 23, 2024, and over the history we have for it it has declined 88.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7371 per EA |
|---|---|
| All-time high | $6.2147 (Nov 13, 2024) |
| All-time low | $0.7371 (Jun 17, 2026) |
| 52-week high | $3.4354 |
| 52-week low | $0.7371 |
| Median price | $2.9105 |
| Average price | $2.9818 |
| Largest weekly change | -25.7% (Feb 18, 2026) |
| Weeks tracked | 88 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IVABRADINE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IVABRADINE HCL 7.5 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.7371 per EA (NDC 70710147206), effective Jun 24, 2026.
How has the price of IVABRADINE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for IVABRADINE HCL 7.5 MG TABLET has declined 88.1%. It has been tracked across 88 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for IVABRADINE HCL 7.5 MG TABLET?
Since Oct 23, 2024, the NADAC for IVABRADINE HCL 7.5 MG TABLET has ranged from a low of $0.7371 (Jun 17, 2026) to a high of $6.2147 (Nov 13, 2024), with a median of $2.9105 per EA.
Are there cheaper alternatives to IVABRADINE HCL 7.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as IVABRADINE HCL 7.5 MG TABLET, but none are currently priced below it.
Who manufactures IVABRADINE HCL 7.5 MG TABLET?
IVABRADINE HCL 7.5 MG TABLET (NDC 70710147206) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification